Key statistics
On Monday, Personalis Inc (PSNL:NMQ) closed at 9.06, -21.22% below its 52-week high of 11.50, set on Jan 22, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 8.26 |
|---|---|
| High | 9.39 |
| Low | 8.25 |
| Bid | 8.35 |
| Offer | 8.87 |
| Previous close | 9.06 |
| Average volume | 1.44m |
|---|---|
| Shares outstanding | 104.63m |
| Free float | 60.70m |
| P/E (TTM) | -- |
| Market cap | 947.96m USD |
| EPS (TTM) | -0.9088 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
- Personalis Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights
- Personalis to Participate in the TD Cowen 46th Annual Healthcare Conference
- Personalis to Announce Fourth Quarter and Full Year 2025 Financial Results
- Personalis Receives Medicare Coverage for NeXT Personal® in Lung Cancer Surveillance
- Personalis Announces New Publication Expanding Evidence for Ultrasensitive ctDNA Monitoring of Cancer Immunotherapy Response Across Solid Tumors
- Personalis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
- Personalis Pioneers Advancement in MRD Testing with the Launch of its Real-Time Variant Tracker™
- Personalis Reports Select Preliminary Fourth Quarter and Full Year 2025 Results and Recent Highlights
- Personalis Announces New Publication Applying Ultrasensitive ctDNA Testing to Monitoring Cancer Immunotherapy Response Across Solid Tumors
- New Publication Demonstrates the Importance of NeXT Personal Ultrasensitive Detection of Residual Disease in Lung Cancer
More ▼
